Nanexa surges on $1.33 billion Novo Nordisk licensing deal
Shares in Swedish microcap Nanexa more than doubled at the open in Stockholm on Friday after the drug-delivery group disclosed a global licensing agre
PharmaShell
Every Fin-node story mentioning PharmaShell — 1 story, newest first.
PharmaShell · 1 story